Functional and molecular analysis of the double-positive stage-specific CD8 enhancer E8III during thymocyte development

被引:33
作者
Feik, N
Bilic, I
Tinhofer, J
Unger, B
Littman, DR
Ellmeier, W
机构
[1] Med Univ Vienna, Inst Immunol, Vienna Competence Ctr, A-1090 Vienna, Austria
[2] Competence Ctr Biomol Therapeut, Vienna, Austria
[3] NYU, Sch Med, Howard Hughes Med Inst, Mol Pathogenesis Program,Skirball Inst Biomol Med, New York, NY 10016 USA
基金
奥地利科学基金会;
关键词
D O I
10.4049/jimmunol.174.3.1513
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several developmental stage-, subset-, and lineage-specific Cd8 cis-regulaton, regions have been identified. These include the E8(III) enhancer, which directs expression in double-positive (DP) thymocytes, and E8(II). which is active in DP cells and CD8(+) T cells. Using a transgenic reporter expression assay, we identified a 285-bp core fragment of the E8(III). enhancer that retains activity in DP thymocytes. In vitro characterization of the core enhancer revealed five regulatory elements that are required for fall enhancer activity, suggesting that multiple factors contribute to the developmental stage-specific activity. Furthermore. deletion of E8(III) in the mouse germline showed that this enhancer is required for nonvariegated expression of CD8 in DP thymoc yteswhen E8(II) is also deleted. These results indicate that E8(III) is one of the cis-elements that contribute to the activation of the Gd8a and Gd8b gene complex during T cell development.
引用
收藏
页码:1513 / 1524
页数:12
相关论文
共 41 条
[31]   New perspectives on a developmental dilemma: the kinetic signalling model and the importance of signal duration for the CD4/CD8 lineage decision [J].
Singer, A .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (02) :207-215
[32]   EXPRESSION OF THE CD4 GENE REQUIRES A MYB TRANSCRIPTION FACTOR [J].
SIU, G ;
WURSTER, AL ;
LIPSICK, JS ;
HEDRICK, SM .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (04) :1592-1604
[33]   CD-69 EXPRESSION DURING SELECTION AND MATURATION OF CD4+8+ THYMOCYTES [J].
SWAT, W ;
DESSING, M ;
VONBOEHMER, H ;
KISIELOW, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) :739-746
[34]   PHENOTYPIC CHANGES ACCOMPANYING POSITIVE SELECTION OF CD4+ CD8+ THYMOCYTES [J].
SWAT, W ;
DESSING, M ;
BARON, A ;
KISIELOW, P ;
VONBOEHMER, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (09) :2367-2372
[35]  
Taniuchi I, 2004, ADV IMMUNOL, V83, P55
[36]   TARGETED DISRUPTION OF THE MURINE INT-1 PROTOONCOGENE RESULTING IN SEVERE ABNORMALITIES IN MIDBRAIN AND CEREBELLAR DEVELOPMENT [J].
THOMAS, KR ;
CAPECCHI, MR .
NATURE, 1990, 346 (6287) :847-850
[37]   DEVELOPMENT OF MATURE CD8+ THYMOCYTES - SELECTION RATHER THAN INSTRUCTION [J].
VANMEERWIJK, JPM ;
GERMAIN, RN .
SCIENCE, 1993, 261 (5123) :911-915
[38]   THE SURFACE PHENOTYPE OF DENDRITIC CELLS PURIFIED FROM MOUSE THYMUS AND SPLEEN - INVESTIGATION OF THE CD8 EXPRESSION BY A SUBPOPULATION OF DENDRITIC CELLS [J].
VREMEC, D ;
ZORBAS, M ;
SCOLLAY, R ;
SAUNDERS, DJ ;
ARDAVIN, CF ;
WU, L ;
SHORTMAN, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :47-58
[39]   CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen [J].
Vremec, D ;
Pooley, J ;
Hochrein, H ;
Wu, L ;
Shortman, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :2978-2986
[40]   Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion [J].
White, JK ;
Auerbach, W ;
Duyao, MP ;
Vonsattel, JP ;
Gusella, JF ;
Joyner, AL ;
MacDonald, ME .
NATURE GENETICS, 1997, 17 (04) :404-410